- Drug Pipelines
- April 2025
- 40 Pages
Global
From €1103EUR$1,250USD£954GBP
- Drug Pipelines
- April 2025
- 60 Pages
Global
From €1103EUR$1,250USD£954GBP
- Drug Pipelines
- April 2025
- 60 Pages
Global
From €1103EUR$1,250USD£954GBP
- Drug Pipelines
- April 2025
- 60 Pages
Global
From €1103EUR$1,250USD£954GBP
- Drug Pipelines
- April 2025
- 60 Pages
Global
From €1103EUR$1,250USD£954GBP
- Report
- July 2025
- 177 Pages
Global
From €3971EUR$4,500USD£3,434GBP
- Report
- June 2025
- 185 Pages
Global
From €3971EUR$4,500USD£3,434GBP
- Report
- June 2025
- 183 Pages
Global
From €3971EUR$4,500USD£3,434GBP
- Report
- February 2025
- 180 Pages
Global
From €3971EUR$4,500USD£3,434GBP
- Report
- February 2025
- 180 Pages
Global
From €3971EUR$4,500USD£3,434GBP
- Report
- February 2025
- 185 Pages
Global
From €3971EUR$4,500USD£3,434GBP
- Report
- February 2025
- 184 Pages
Global
From €3971EUR$4,500USD£3,434GBP
- Report
- February 2025
- 182 Pages
Global
From €3971EUR$4,500USD£3,434GBP
- Report
- November 2024
- 180 Pages
Global
From €3971EUR$4,500USD£3,434GBP
- Report
- June 2025
- 150 Pages
Global
From €2646EUR$2,999USD£2,289GBP
- Report
- September 2025
- 378 Pages
Global
From €5162EUR$5,850USD£4,465GBP
- Report
- September 2025
- 287 Pages
Global
From €5162EUR$5,850USD£4,465GBP
- Report
- September 2025
- 154 Pages
Global
From €5162EUR$5,850USD£4,465GBP
- Report
- September 2025
- 200 Pages
Global
From €5162EUR$5,850USD£4,465GBP
- Report
- September 2025
- 414 Pages
Global
From €5162EUR$5,850USD£4,465GBP

Gene therapy is a form of genomics that involves the introduction of genetic material into a patient's cells to treat or prevent a disease. It is a rapidly growing field of medicine, with the potential to revolutionize the treatment of genetic diseases. Gene therapy works by introducing a healthy gene into a patient's cells, replacing a defective gene or providing a missing gene. This can be done through a variety of methods, such as viral vectors, gene editing, and stem cell therapy.
Gene therapy has the potential to provide long-term, curative treatments for a wide range of genetic diseases, including cancer, cystic fibrosis, and hemophilia. It is also being explored as a potential treatment for other conditions, such as Alzheimer's disease and Parkinson's disease.
Gene therapy is a rapidly growing field, with many companies investing in research and development. Companies in the gene therapy market include Editas Medicine, Intellia Therapeutics, CRISPR Therapeutics, and Spark Therapeutics. Show Less Read more